An oncology study of outpatients with cancer showed that although over half had adequate initial pain management, over 11% were undertreated during follow-up. The Eastern Cooperative Oncology Group (ECOG), studying over 2700 patients from 38 centers, accessed pain through patient self-ranking. Over a quarter of the patients who had no pain initially experienced moderate to severe pain at follow-up. The solid tumor cancers studied were breast (almost 50%), and colorectal, prostate, and lung.
As published in the Journal of Clinical Oncology, results show that “pain is not only prevalent but also persistent and dynamic” and pain management reassessment is of the utmost importance.
To read the article, click here.
Find the journal article here.